UBS Dividend Ruler (S:0P0001IHQ7)
18.88
+0.44
(+2.38%)
USD |
Sep 30 2024
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
| Maximum Management Fee | Annualized Total Returns Since Inception (Daily) | Alpha (vs Category) (3Y) | Forecasted Dividend Yield |
|---|---|---|---|
| -- | -- | -- | -- |
| Total Market Value (Net) | Beta (vs Category) (3Y) | Max Drawdown (Since Inception) | Fwd Dividend Yield (Long) |
| Upgrade | Upgrade | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| General | |
| Security Type | |
| Equity Style | |
| Fixed Income Style | |
| Broad Asset Class | |
| Broad Category | |
| Category Name | |
| Category Index | |
| Global Category Name | |
| YCharts Categorization | US Large Cap Blend |
| YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
| Fund Owner Firm Name | |
| Prospectus Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| 100.0% | |
| Manager Tenure | |
| Christopher Shea | 5.26 yrs |
| Edmund Tran | 5.26 yrs |
| Jeffrey Hans | 5.26 yrs |
| Jeremy Zirin | 5.26 yrs |
Annual Total Returns Versus Peers
As of November 14, 2024.
Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | -- | -- | -- |
| Stock | -- | -- | -- |
| Bond | -- | -- | -- |
| Convertible | -- | -- | -- |
| Preferred | -- | -- | -- |
| Other | -- | -- | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Microsoft Corp | 11.00% | 426.10 | 0.21% |
| Broadcom Inc | 6.71% | 172.63 | -0.55% |
| Oracle Corp | 5.17% | 188.55 | -0.57% |
| Taiwan Semiconductor Manufacturing Co Ltd ADR | 4.64% | 189.51 | 1.53% |
| JPMorgan Chase & Co | 4.24% | 243.43 | 0.94% |
| The Home Depot Inc | 4.04% | 410.71 | 0.13% |
| UnitedHealth Group Inc | 3.80% | 598.51 | -1.21% |
| Morgan Stanley | 3.80% | 133.71 | 0.72% |
| BlackRock Inc | 3.47% | 1052.54 | 2.09% |
| Abbott Laboratories | 3.18% | 115.70 | -0.03% |
Fees & Availability
| Fees | |
| Negotiable Fee | No |
| Administrative Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Trustee Fee | -- |
| Purchase Details | |
| Open to New Investors | No |
| Open to Existing Investors | No |
| Minimum Initial Investment | -- |
| Minimum Subsequent Investment | -- |
Basic Info
| Investment Strategy | |
| General | |
| Security Type | |
| Equity Style | |
| Fixed Income Style | |
| Broad Asset Class | |
| Broad Category | |
| Category Name | |
| Category Index | |
| Global Category Name | |
| YCharts Categorization | US Large Cap Blend |
| YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
| Fund Owner Firm Name | |
| Prospectus Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| 100.0% | |
| Manager Tenure | |
| Christopher Shea | 5.26 yrs |
| Edmund Tran | 5.26 yrs |
| Jeffrey Hans | 5.26 yrs |
| Jeremy Zirin | 5.26 yrs |
Fundamentals
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Forecasted Dividend Yield | -- |
| Forecasted PE Ratio | -- |
| Forecasted Price to Sales Ratio | -- |
| Forecasted Price to Book Ratio | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Last Annual Report Date | -- |
| Last Prospectus Date | -- |
| Attributes | |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |